Enter assignee name

EPO Patents = 3

Forward Citations = 4

Loading Chart...

13 inventors (with patents filed for the assignee):

Ming Zhao (3 out of 67 patents)

Chan-Jung Li (3 out of 3 patents)

David Chih-Kuang Chou (3 out of 4 patents)

4. Jin-Ding Huang (3 out of 4 patents)

5. Shu-Wen Kuo (3 out of 4 patents)

6. Yu-En Tien (3 out of 3 patents)

7. Shin-Jr Tsai (3 out of 3 patents)

8. Shi-Qi Peng (2 out of 2 patents)

9. Jian-Hui Wu (2 out of 2 patents)

10. Yu-Ji Wang (2 out of 2 patents)

11. Qi-Qi Feng (2 out of 2 patents)

12. Shiqi Peng (1 out of 2 patents)

13. Xueyun Jiang (1 out of 1 patent)

14. Jianhui Wu (2 patents)

15. Yuji Wang (0 patent)

6 patents: Sort by Forward Citations

1. 11241424 - Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester (2022-02-08),

2. 11234974 - Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester (2022-02-01),

3. 10806798 - Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting (2020-10-20),

4. 10351594 - Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging (2019-07-16),

5. 10183018 - Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester (2019-01-22),

6. 9890193 - Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof (2018-02-13),

Shanghai Lumosa Therapeutics Co., Ltd. is a leading biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for patients with unmet medical needs. The company focuses on creating novel treatments across various therapeutic areas, including oncology, immunology, and rare diseases, with a mission to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#339 in Shanghai

#3,900 in China

Shanghai, China

Shanghai Lumosa Therapeutics Co., Ltd.